Soros Fund Management - XERIS PHARMACEUTICALS INC ownership

XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 101 filers reported holding XERIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.

Quarter-by-quarter ownership
Soros Fund Management ownership history of XERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$25,000
-95.3%
4,248
-97.9%
0.00%
-91.7%
Q2 2020$532,000200,0000.01%
Other shareholders
XERIS PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Sessa Capital IM, L.P. 3,661,237$14,901,0000.56%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,553,398$26,672,0000.47%
Alpine Global Management, LLC 354,524$1,443,0000.20%
DELTEC ASSET MANAGEMENT LLC 275,500$1,121,0000.15%
Kamunting Street Capital Management, L.P. 67,594$275,0000.11%
IHT Wealth Management, LLC 340,147$1,384,0000.09%
Redmile Group, LLC 1,358,825$5,530,0000.08%
GSA CAPITAL PARTNERS LLP 173,318$705,0000.08%
ArrowMark Colorado Holdings LLC 1,815,091$7,387,0000.06%
GPS Wealth Strategies Group, LLC 49,025$200,0000.05%
View complete list of XERIS PHARMACEUTICALS INC shareholders